Levine Steven M, Lester Mary E, Fontenot Benjamin, Allen Robert J
Institute of Reconstructive Plastic Surgery, New York University Langone Medical Center, New York, NY, USA.
Ann Plast Surg. 2011 May;66(5):513-7. doi: 10.1097/SAP.0b013e3182012597.
In 2009, 86,424 breast reconstructions were performed in the United States, with 76% being implant-based procedures. Capsular contracture and infection are the 2 most cited indications for implant explantation, resulting in a reconstruction failure. However, several patients are dissatisfied with implant reconstruction even without the aforementioned complications. We hypothesize that microvascular autologous tissue transfer with perforator free-flap breast reconstruction provides an excellent salvage modality in the face of an unsatisfactory implant reconstruction, resulting in an improved cosmetic and functional outcome, with low risk of complications. We retrospectively reviewed the charts of patients in the senior author's practice who underwent perforator flap breast reconstruction between the years 1998 through 2008, and identified all patients who had prior implant reconstruction. Indications for implant explantation, medical history, operative procedure, and postoperative complications were reviewed. During the study period, 1846 perforator flaps were performed. We found 191 patients who underwent autologous breast reconstruction after implant reconstruction with a total of 284 flaps (15.4%). The most frequent patient complaint was unnatural appearance and feel of the implants (Baker I or Baker II), and the majority of patients had not undergone radiation. Most patients were reconstructed using abdominal flaps with 164 deep inferior epigastric perforators, 50 superior gluteal artery perforators, 30 superficial inferior epigastric arteries, 35 inferior gluteal artery perforators, and 5 transverse upper gracilis. The total complication rate was 7.4%, with most complications related to wound healing at the donor site. There were 3 flap losses (1%), all of which were later successfully reconstructed with another perforator flap. Implant failures are traditionally thought to be in patients with Baker grade III/IV capsular contractures and in patients status post radiation therapy. However, in our study, the majority of patients seeking perforator flap reconstruction after implant reconstruction complained of an unnatural feel and appearance of their breasts, and did not have a severe capsular contracture deformity (Baker III/IV), nor had they undergone radiation. This suggests that implant reconstruction can lead to patient dissatisfaction severe enough to warrant removal even with Baker I/II results, and not in the setting of postradiation changes.
2009年,美国共进行了86424例乳房重建手术,其中76%为基于植入物的手术。包膜挛缩和感染是最常被提及的取出植入物的指征,这会导致重建失败。然而,即使没有上述并发症,仍有一些患者对植入物重建不满意。我们推测,在植入物重建效果不理想的情况下,采用带穿支游离皮瓣的微血管自体组织移植进行乳房重建是一种很好的补救方式,可改善美容效果和功能,且并发症风险较低。我们回顾性分析了资深作者诊所中1998年至2008年间接受穿支皮瓣乳房重建患者的病历,并确定了所有曾接受过植入物重建的患者。对取出植入物的指征、病史、手术过程和术后并发症进行了回顾。在研究期间,共进行了1846例穿支皮瓣手术。我们发现191例患者在植入物重建后接受了自体乳房重建,共使用了284块皮瓣(15.4%)。患者最常见的抱怨是植入物外观和手感不自然(贝克I级或贝克II级),且大多数患者未接受过放疗。大多数患者采用腹部皮瓣进行重建,其中包括164块腹壁下深穿支皮瓣、50块臀上动脉穿支皮瓣、30块腹壁下浅动脉皮瓣、35块臀下动脉穿支皮瓣和5块股薄肌皮瓣。总并发症发生率为7.4%,大多数并发症与供区伤口愈合有关。有3例皮瓣坏死(1%),所有患者后来均成功采用另一块穿支皮瓣进行了重建。传统上认为植入物失败主要发生在贝克III/IV级包膜挛缩患者和放疗后的患者中。然而,在我们的研究中,大多数在植入物重建后寻求穿支皮瓣重建的患者抱怨乳房外观和手感不自然,且没有严重的包膜挛缩畸形(贝克III/IV级),也未接受过放疗。这表明,即使是贝克I/II级的结果,植入物重建也可能导致患者严重不满,足以促使其取出植入物,而非在放疗后的情况下。